Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

被引：0
|
作者：
Wim A. Wuyts
Caroline Dahlqvist
Hans Slabbynck
Marc Schlesser
Natacha Gusbin
Christophe Compere
Sofie Maddens
Yuan-Chi Lee
Klaus-Uwe Kirchgaessler
Karen Bartley
Benjamin Bondue
机构：
[1] University Hospitals Leuven,Department of Respiratory Medicine, Unit for Interstitial Lung Diseases
[2] CHU UCL Namur Site Godinne,Department of Respiratory Medicine
[3] ZNA Middelheim,Department of Respiratory Medicine
[4] Centre Hospitalier de Luxembourg,Department of Respiratory Medicine
[5] CHR de la Citadelle,undefined
[6] CHIREC Hospital,undefined
[7] AZ Groeninge,undefined
[8] Genentech,undefined
[9] Inc.,undefined
[10] F. Hoffmann-La Roche,undefined
[11] Ltd.,undefined
[12] Erasme University Hospital,undefined
来源：
Respiratory Research | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Lee, Yuan-Chi
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [2] Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    BMJ OPEN RESPIRATORY RESEARCH, 2018, 5 (01):
  • [3] Proof-Registry: A Prospective Observational Registry To Describe The Disease Course And Outcomes Of Idiopathic Pulmonary Fibrosis Patients In A Real-World Clinical Setting
    Wuyts, W.
    Bondue, B.
    Slabbynck, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Joos, G. F.
    Berrens, M.
    Giot, C.
    Dahlqvist, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [4] Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
    Tzouvelekis, Argyrios
    Karampitsakos, Theodoros
    Ntolios, Paschalis
    Tzilas, Vasilios
    Bouros, Evangelos
    Markozannes, Evangelos
    Malliou, Ioanna
    Anagnostopoulos, Aris
    Granitsas, Andreas
    Steiropoulos, Paschalis
    Dimakou, Katerina
    Chrysikos, Serafeim
    Koulouris, Nikolaos
    Bouros, Demosthenes
    FRONTIERS IN MEDICINE, 2017, 4 : 1 - 1
  • [5] Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
    Wim A. Wuyts
    Caroline Dahlqvist
    Hans Slabbynck
    Marc Schlesser
    Natacha Gusbin
    Christophe Compere
    Sofie Maddens
    Shemra Rizzo
    Klaus-Uwe Kirchgaessler
    Karen Bartley
    Benjamin Bondue
    Pulmonary Therapy, 2022, 8 : 181 - 194
  • [6] Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Rizzo, Shemra
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    PULMONARY THERAPY, 2022, 8 (02) : 181 - 194
  • [7] Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
    Qiu, Ying
    Zhu, Julia
    Elpers, Brandon
    Jiang, Jenny
    Ogbomo, Adesuwa
    Mallampati, Rajesh
    Byrne, Clare
    Tang, Jackson
    Fischer, Aryeh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] Proof: A Prospective Observational Registry To Describe The Disease Course And Outcomes Of Idiopathic Pulmonary Fibrosis Patients In A Real-World Clinical Setting. Proof-Registry Belgium Luxembourg: Comorbidities In 175 Ipf Patients At Inclusion
    Wuyts, W.
    Bondue, B.
    Dahlqvist, C.
    Slabbynck, H.
    Schlesser, M.
    Richir, K.
    Compere, C.
    Gusbin, N.
    Joos, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Brunnemer, Eva
    Waelscher, Julia
    Tenenbaum, Svenja
    Hausmanns, Julia
    Schulze, Karen
    Seiter, Marianne
    Heussel, Claus Peter
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    RESPIRATION, 2018, 95 (05) : 301 - 309
  • [10] REAL-WORLD CLINICAL CHARACTERISTICS OF 112 PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: UPDATE FROM THE TRIO HEALTH IPF REGISTRY
    Frantz, R. P.
    Rane, D.
    Nathan, S. D.
    Lancaster, L.
    Frost, A. E.
    Chakinala, M. M.
    Oudiz, R. J.
    Farber, H. W.
    VALUE IN HEALTH, 2021, 24 : S219 - S219
12345